Journal of Antimicrobial Chemotherapy, Vol 40, 291-294, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
I Poggesi, R Spinelli, E Frigerio, M Strolin Benedetti, L Carra, D Sassella and R Rimoldi
The pharmacokinetics of ritipenem acoxil, the oral prodrug of the
antibiotic ritipenem, were studied in volunteers after single and repeated
dosing (500 mg, three times daily for 10 days). Concentrations of ritipenem
and open beta-lactam ring metabolites were measured using HPLC/UV.
Ritipenem did not accumulate significantly in plasma, owing to its
half-life of about 0.7 h; the area under the curve for 0-8 h was on average
about 10 mg x h/L. Plasma pharmacokinetics of ritipenem and metabolites
were time-independent. A decrease of ritipenem renal clearance (87 versus
132 mL/min) and a slight increase in the amount of metabolites excreted in
urine were observed following repeated dosing.
ORIGINAL ARTICLES
A study of the pharmacokinetics and tolerability of ritipenem acoxil in healthy volunteers following multiple oral dosing
Pharmacia and Upjohn, Nerviano, Milan, Italy.
![]()
CiteULike
Connotea
Del.icio.us What's this?